CD4 and HIV infectious disease: In this cross-sectional study we compared changes in a panel of neuronal biomarkers with respect to their capacity to detect and characterize neuronal injury across the spectrum of untreated systemic disease progression from early or ‘primary’ HIV infection (PHI), through systemic progression with falling blood CD4+ T cells, to the presentation with overt HAD.